离维也纳2016年世界肺癌大会投稿截止还有2天，欢迎积极投稿参加中国日

离维也纳2016年世界肺癌大会投稿截止还有2天，欢迎积极投稿参加中国日

各位尊敬的联盟成员，大家好，



2016年12月4日至7日将在奥地利维也纳举办第17界世界肺癌大会，大会摘要投稿的截止日期为7月21日，请大家积极踊跃参与投稿，届时延续往年传统，联盟主席白春学教授将继续组织“中国日”活动，并遴选优秀的国内研究项目进行大会专场的汇报。


祝好
白春学主席


大会摘要投稿链接：
http://wclc2016.iaslc.org/abstracts-scholarships/abstracts/


2015年世界肺癌大会“中国日”专场报道
世界肺癌大会（WCLC）：「国际范中国梦」三大实现



2015年世界肺癌大会优秀青年研究者奖介绍
一位住院医生眼中的世界肺癌大会（WCLC）



摘要投稿英文指南：
The Core Program and Regional Organizing Committee for the IASLC 17th World Conference on Lung Cancer are inviting the submission of scientific abstracts. Authors are asked to submit abstracts under one of the following categories:
Epidemiology/Tobacco Control & Cessation/Prevention

Biology/Pathology

Radiology/Staging/Screening

Pulmonology

Early Stage NSCLC

Locally Advanced NSCLC

Advanced NSCLC

SCLC/Neuroendocrine Tumors

Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies

Surgery

Radiotherapy

Chemotherapy/Targeted Therapy/Immunotherapy

Palliative Care/Ethics

Trial Design/Statistics

Regional Aspects/Health Policy/Public Health

Scientific Co-operation (Clinical Trials in Progress are to be submitted under this category)

Nurses

Patient Support & Advocacy Groups


 Abstract Deadlines
 Clinical Trials In Progress
The Conference will also accept submissions of abstracts on Clinical Trials in Progress

They should be submitted in the submission category ‘Scientific Co-operation/Research Group’


 Submission Guidelines
General
Abstracts will be accepted in English only

An international panel of reviewers will review all abstracts anonymously

There is no fee for submitting an abstract

There is no limit to the number of abstracts you may submit (however an individual may not be offered more than 2 oral presentations)

All Abstracts accepted by the Scientific Committee will be published in the Journal of Thoracic Oncology (JTO) and the Conference website prior to the meeting and it is mandatory to agree to this at the time of submission


Step 1. Title & Topic
The abstract title must not exceed 125 characters in length; this includes spaces.


Step 2. Authors
The presenting author of an accepted abstract must be registered by October 21, 2016

There is no limit to the number of co-authors per abstract

Financial Disclosure information needs to be completed for EACH co-author at the time of submission through the online abstract submission form; however, information can be provided by the submitting author

The submitter can view the status of co-author disclosures by clicking on ‘Authors’ sections of the abstract. Those with incomplete disclosures are denoted in red

If you would like an assistant or other person to receive notifications regarding the status of an abstract, please enter their email address on the text field provided below the list of co-authors

Please note your preferred presentation format. If you would not be comfortable giving an oral presentation, please select Poster Only. NOTE: Selecting Poster/Oral does not guarantee you will be assigned an oral abstract presentation upon acceptance; the final presentation type is determined by the International Scientific Abstract Review Committee


Step 3. Disclosure
Disclosure of relevant financial relationships:

Nature of relevant financial relationship

Name of company(s)


Presentation(s) content: Faculty responsibility:

The presenter warrants that nothing in their presentation is libelous or will infringe the rights of any third party

Presenter also warrants that for any third party materials incorporated into their presentation, they have obtained all necessary permission from the copyright owner of such material

Upon request Presenter agrees to furnish copies of said permission(s) to IASLC

The Presenter is responsible for all fees, royalties and other charges for the use of materials

The Presenter shall indemnify IASLC for all damages, costs and expenses, including attorneys’ fees, incurred by IASLC as a result of a violation of this paragraph

Presentations must give a balanced view of therapeutic options

Use of generic names will contribute to this impartiality

If the CME educational material or content includes trade names, where available trade names from several companies should be used, not just trade names from a single company


Tobacco related remuneration


Step 4. Abstract Text
Do not include Title or Author data in the body of your abstract (There are specific places for Title and Author)

Abstracts may be entered directly into the site or copied and pasted

Research work should be original and innovative. Work can be presented prior to the IASLC 17th WCLC, but MUST include new information/data

Abstracts must not exceed 400 words in length (not including title and authors)

Tables may be included and each will count as 100 words

A maximum of 2 images may be included; each will count as 100 words

Tables, images and graphs must be uploaded in JPG or TIFF format at 300 dpi and 100% size. Any higher resolution is acceptable.

Abstracts must be structured with the following:

Background

Methods

Results

Conclusion



Step 5. Preview & Submit
Please proofread your submission prior to submitting

Once submitted, you will no longer be able to make edits to the abstract. If you need to make changes prior to the submission deadline, please contact us at wclc2016-abstracts at icsevents.com

Please carefully review the affiliation of all your co-authors as this is how it will appear in the JTO and as well as the IASLC WCLC 2016 Scientific Program


 Late-Breaking Abstract Submission
In order for an abstract to be considered for Late Breaking Abstract status, the submitting author must submit a place holder (including author information and disclosure) abstract before the extended July 21, 2016, deadline

The results and conclusion can be omitted but the type of data that will be presented in the Late-Breaking Abstract must be described as well as why Late-Breaking status is required

If you wish to apply for late breaking privileges, you must submit an abstract by the extended submission deadline July 21, 2016

To apply for late breaking privileges you must sent an email to wclc2016-abstracts at icsevents.com, indicating your abstract ID number and explaining why data is not yet available and when you expect it to become available

The Core Program Committee will then review your abstract and application. If your application is approved you will be notified and instructed on how to submit your new data by the end of August 2016


 Contact
For any inquiries, please contact wclc2016-abstracts at icsevents.com. If your inquiry is regarding a particular draft or submission, please include the abstract ID in your email.